• Text size
  • A
  • A
  • A
Your spotlight on local services

            Contact Us

  @HealthwatchNEL 
@HealthwatchNEL
         01472 361 459

menu

Guide on biosimilar medicine updated

18/06/2019

NHS England has issued an updated guide on the role of biosimilar medicines in the NHS.

The guide also provides support on the safe, effective and consistent use of all biological medicines, including biosimilar medicines, to support patients, in line with the principles of shared decision-making. Increased competition in the biological medicines market has the potential to deliver significant savings for the NHS – of at least £400m to £500m a year by 2020/21 - which can be reinvested in treatments and improving patient care.

Recent